Cargando…
Immune Thrombocytopenic Purpura in Patients with COVID-19
We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were...
Autores principales: | Revuz, Sabine, Vernier, Nathalie, Saadi, Leilah, Campagne, Julien, Poussing, Sophie, Maurier, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350967/ https://www.ncbi.nlm.nih.gov/pubmed/32665935 http://dx.doi.org/10.12890/2020_001751 |
Ejemplares similares
-
Severe immune thrombocytopenic purpura in critical COVID-19
por: Lévesque, Valérie, et al.
Publicado: (2020) -
Immune thrombocytopenic purpura worsened by COVID-19
por: Kim, Chul Soo, et al.
Publicado: (2021) -
Immune thrombocytopenic purpura and COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2023) -
Immune thrombocytopenic purpura and COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2023) -
Immune Thrombocytopenic Purpura in a Patient with Covid-19
por: Zulfiqar, Abrar-Ahmad, et al.
Publicado: (2020)